Low IPSS score and bone marrow hypocellularity in MDS patients predict hematological responses to antithymocyte globulin-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Low IPSS score and bone marrow hypocellularity in MDS patients predict hematological responses to antithymocyte globulin

Published:2007-05-17 Issue:7 Volume:21 Page:1436-1441
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Lim Z Y,Killick S,Germing U,Cavenagh J,Culligan D,Bacigalupo A,Marsh J,Mufti G J

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/2404747.pdf

Reference27 articles.

1. Mufti GJ, Stevens JR, Oscier DG, Hamblin TJ, Machin D . Myelodysplastic syndromes: a scoring system with prognostic significance. Br J Haematol 1985; 59: 425–433.

2. Mufti GJ, Figes A, Hamblin TJ, Oscier DG, Copplestone JA . Immunological abnormalities in myelodysplastic syndromes. I. Serum immunoglobulins and autoantibodies. Br J Haematol 1986; 63: 143–147.

3. Voulgarelis M, Giannouli S, Ritis K, Tzioufas AG . Myelodysplasia-associated autoimmunity: clinical and pathophysiologic concepts. Eur J Clin Invest 2004; 34: 690–700.

4. Billstrom R, Johansson H, Johansson B, Mitelman F . Immune-mediated complications in patients with myelodysplastic syndromes – clinical and cytogenetic features. Eur J Haematol 1995; 55: 42–48.

5. Hamblin TJ . Immunological abnormalities in myelodysplastic syndromes. Semin Hematol 1996; 33: 150–162.

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Outcomes, Survival, and Predictors in Lower-Risk Myelodysplastic Syndrome Patients Treated with Cyclosporine A;Acta Haematologica;2024-02-17

2. Management of Patients with Lower-Risk Myelodysplastic Neoplasms (MDS);Current Oncology;2023-06-27

3. Myelodysplastic syndromes: 2023 update on diagnosis, risk‐stratification, and management;American Journal of Hematology;2023-06-08

4. Myelodysplastic syndrome: Approach to diagnosis in the era of personalized medicine;Seminars in Diagnostic Pathology;2023-05

5. Updates in Classification of Myelodysplastic Syndrome;The Cancer Journal;2023-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3